Table 1.
Magnitude of skeletal changes in mice lacking total, local bone, liver-derived, and endocrine IGF-I actions
| Total IGF-I KOa | Local bone IGF-I KO
|
Liver IGF-I KOd | Endocrine IGF-I KOe | ||
|---|---|---|---|---|---|
| Chondrocyte IGF-I KOb | Osteoblast IGF-I KOc | ||||
| Serum IGF-I | 100% ↓ | Normal | Normal | 75% ↓ | 97.5% ↓ |
| Length | 40% ↓ | 7% ↓ | 14% ↓ | Normal | 6% ↓ |
| Cortical bone width | 38% ↓ | 7% ↓ | 20% ↓ | 9% ↓ | 18% ↓ |
| Cortical vBMD | 30% ↓ | 4% ↓ | 5% ↓ | 7% ↓ | 11% ↓ |
| Trabecular BV/TV | 55% ↑ | ND | 20% ↓f | 10–20% ↓ | 8% ↓f |
| Bone formation rate | 70% ↓ | ND | 48% ↓ | ND | ND |
| Mineral apposition rate | 40% ↓ | ND | 38% ↓ | ND | ND |
ND, Not determined; vBMD, volumetric BMD; BV/TV, bone volume/ total volume.
Data for length, bone width, and cortical vBMD were derived from Mohan et al. (50), whereas data for trabecular BV/TV, bone formation rate, and mineral apposition rate were derived from Bikle et al. (153).
Data for chondrocyte IGF-I KO mice were derived from Govoni et al. (52).
Data for osteoblast IGF-I KO mice were derived from Govoni et al. (53).
Data for liver-specific IGF-I KO are summaries of the main findings from several studies using mice with liver-specific IGF-I KO (11,12,58,61,62,155).
Data for length and bone width of endocrine IGF-I KO were derived from triple KO mice lacking liver-derived IGF-I, total IGFBP-3, and total ALS (61), whereas data for cortical vBMD and trabecular BV/TV were derived from double KO mice lacking liver-derived IGF-I and ALS (62).
Not significant.